PAC ANESTESIA-1 B3
Contenido
REFERENCIAS

INTRODUCCIÓN Y RESPUESTA NEUROENDOCRINA
  1. Guyton AC. Tratado de fisiología médica. 8ª ed. México: Nueva Editorial Interamericana, 1992:845.

  2. Harrison’s. Principles of internal medicine.13th. ed. Philadelphia: Mc Graw-Hill, Inc.1994: vol 2:1883

  3. Weissman CH. The metabolic response to stress. Anesthesiology 1990; 73:308-327.

  4. Kehlet H. Modification of responses to surgery and anesthesia by neural blockade. En: Cousins MJ. ed. Neural blockade in clinical anesthesia an management of pain. Philadelphia: Lippincott, 1987; 145-188.

  5. Yoshiyuki N. Responses of plasma ACTH, cortisol and citokines during and after upper abdominal surgery. Anesthesiology 1992; 77:3:426-31.

  6. Bonica JJ. The management of pain. 2nd ed. Philadelphia. Lea & Febiger, 1990; vol 1:368-7.

  7. Carli F. The independent metabolic effects of halothane and isoflurane anaesthesia. Acta Anaesth Scand 1993; 37:672-8.
DIABETES MELLITUS
  1. National Diabetes Group. Diabetes in America. 2nd. edition. Bethesda, 1995; 449-56.

  2. Ohkawa H. Clinical study on intraoperative hyperketonemia in non diabetic surgical patients. Masui 1993; 42 (12): 1803-7.

  3. Seki S. Clinical features of hyperosmolar hyperglicemic non ketotic diabetes coma. J Thorac Cardiovasc Surg 1986; 91: 867-73.

  4. Perneger TU. End-stage renal disease attribuitable to diabetes mellitus. Ann Int Med 1994, 121: 912-18.

  5. Burgos L. Increased intraoperative cardiovascular morbidity in diabetes with autonomic neuropathy. Anesthesiology 1989; 70 (4): 591-97.

  6. Hayes TA. The endocrine pancreas. Medicine for anesthetists. Vickers M.D. Edition Oxford Blackxwell Scientific. 1982: 497-514.

  7. Pezzarosa A. Perioperative management of diabetic subjects. Diabetes care 1988; 11 (1): 52-58.

  8. Waltz L. Perioperative management of diabetes mellitus. Anesthesiology  1981; 55: 104-109.

  9. Alberti KG, Thomas DJ. The management of the diabetes during surgery. Br J Anesth 1979; 51: 693-710.

  10. Gill GV. Management of diabetes during open heart surgery. Br J Surg 1981; 68: 171-72.

  11. Alberti KG. Insulin dependent diabetes during the perioperative period. Anesthesia 1989; 39: 629-37.

  12. Bowen DJ. Perioperative management of insulin-dependent patient. Anesthesia 1982; 37: 852-55.

  13. Brussell T. Anesthesia and diabetes mellitus. Anesthesist 1994; 43 (5): 333-46.

  14. Roizen M. Perioperative management of the diabetic patient. ASA refresher courses 1995; 412:1-6.

  15. Peterson L. Insulin adsorbance to polivinyl chloride surfaces. Diabetes 1976; 25: 72-4.

INSULINOMA
  1. Roher HD. Special diagnostic and therapeutic aspects of insulinoma. Chirurg 1997; 68(2):116-21.

  2. Nauck MA. A clamp test to characterize autonomous insulin secretion in patients with insulinoma. Eur J Clin Invest 1997; 27 (2 ): 104-15.

  3. Gagner M. Early experience with laparoscopic resections of islet cell tumors. Surgery 1996; 120 (6): 1051-54.

  4. Stipa V. Diagnostic and the therapeutic strategy of insulinomas. Chirurgie 1997; 121: 667-71.

GLÁNDULA SUPRARRENAL
Síndrome de Cushing
  1. O’ Riordain DS. Long-term outcome of bilateral adrenalectomy in patients with Cushing syndrome. Surgery 1994; 116 (6): 1088-93.

  2. Magiakov MA. Cushing syndrome in children and adolescents. N Engl J Med 1994; 331: 629-36.

  3. Boidin MP. Can etomidate cause an Addisonian crisis ? Acta Anesthesiol Belg 1983; 37 (3):165-70.

  4. Yusa T. The anesthetic management for adrenalectomy. Masui 1992; 41 (7): 1168-74.

  5. La Brocca A. Recurrent thromboembolism in Cushing syndrome. Endocrinol Invest 1997; 20(4): 211-14.

  6. Felig P, Baxter J. Endocrinología y metabolismo. Corteza suprarrenal. Ed. Mc Graw-Hill 1983; 405-537.


    Enfermedad de Addison

  7. Wall T. Endocrine emergencies in anesthesia. ASA Refresher courses 1995; 246: 1-7.

  8. Bruton- Maree N. Acute adrenal insufficiency. A case report CRNA 1993; 4(3): 128-32.

  9. Adams HA. Total IV anesthesia with s-ketamine. Anesthesist 1994; 43(1): 130-33.


    Hiperaldosteronismo primario


  10. Matsuda M. Anesthesiological management in primary aldosteronism. Masui 1994;43(1):130-33.

  11. Kasai H. Anesthetic management in a patient with aldosteronism. Masui 1990; 39(6): 786-91.

  12. Kannan S. Anesthetic management in the Bartter’s syndrome. Can J Anesth 1995;42(9): 808-12.


FEOCROMOCITOMA
  1. Russell T. Endocrine emergencies in anesthesia ASA refresher cources 1995; 161: 1-7.

  2. Saaman N. Diagnosis, localization and management of pheocromocytoma. Cancer 1988; 62: 2451-60.

  3. Freser D. Pheocromocytoma. Arch Surg 1980; 115: 388-91.

  4. Roizen M. Anesthesia for the patients with endocrine disease. Current Reviews in Clinical Anesthesia 1987; 8: 50-55.

  5. Sheldon G. Recent development in the diagnosis of pheocromocytoma. Mayo Clin Proc 1990; 65: 88-95.

  6. Roizen M. Essence of anesthesia practice. Saunders Ed. 1997: 251.

  7. Adams HA. Anesthesia for patients with pheocromocytoma. Anesthesiol Intesivemed 1993; 28 (8): 500-509

  8. Shibata K. Anesthetic management for resection of cardiac pheocromocytoma. Masui 1990; 39 (5): 639-43.

  9. Levin H. Pheocromocytoma and severe protracted postoperative hypoglycaemia. Can J Anesth 1990; 37 (4): 477-78.

HIPERTIROIDISMO
  1. Wissler R. The patient with endocrine disease. Probl in Anesth 1992; 6: 1, 61-85.

  2. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327:94-97.

  3. Brussel T. Perioperative management of endocrine problems: Thyroid, Adrenal Cortex, Pituitary. Refr Courses in Anesth ASA 1990; 18:3, 33-50.

  4. Roizen M. Anesthetic implications of concurrent diseases. En Miller RD (ed) Anesthesia. 4th ed. 1994; 903-1014.

  5. Lancefield M. The sugical patient with thyroid disease. En Goldmann D. Perioperative Medicine. 2nd ed. 1994; 25:251-59.

  6. Geffner DL. Beta-adrenergic blockade for the treatment of hyperthyroidism. Am J Med 1992; 93:61-68.

  7. Matsuki A, Oyama T. The thyroid and anesthesia, endocrinology and the anaesthetist. 1983; 63-79.

  8. Kehlet H. Modification of responses to surgery and anesthesia by neural blockade. En: Cousins MJ, ed. Neural blockade in clinical anesthesia and management of pain. 2nd ed. 1993.

  9. Klein SM. Regional anesthesia for thyroidectomy in two patients with amiodarone induced hyperthyroidism. Anesth Analg 1997; 85:222-24.

  10. Isley WL. Use of esmolol in managing a thyrotoxic patient needing emergency surgery. Am J Med 1990; 89:122-23.

  11. Breivik H. Perianesthetic management of patients with endocrine disease. Acta Anaesth Scand 1996; 40: 1004-15.

  12. Chernow B. Perioperative endocrine and electrolyte emergencies. Can J Anaesth 1990; 37:4, SIXXI- SIXXIII.

  13. Kahky MP. Complicaciones de la cirugía del tiroides y de las glándulas paratiroides. Clin Quir North Am 1993; 2:335-49.

SÍNDROME CARCINOIDE
  1. Marsh HM. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology 1987; 66:89-91.

  2. Norton Jefrey A. Carcinoid tumors. En: De Vita Vincent T, ed. Cancer principles, practice of oncology. 3rd ed, 1989; 39:1303-14.

  3. Mason RA. Carcinoid syndrome - its relevance to the anesthetist. Anaesthesia 1976; 31:22842.

  4. Kaplan LM. Endocrine tumors of the gastrointestinal tract and pancreas. In Harrison’s. Principles of Internal Medicine, 13th ed. 1994; 2:1535-39.

  5. Gray Gary M. Acute diarrhea. En: Dale David C. Scientific American Medicine. 1996; 4:3,6-9.

  6. Badola R.P. The patient with carcinoid syndrome. En: Preanesthetic Assessment. 1994; 2:12-25.

  7. Mason RA. Anaesthesia for a patient with carcinoid syndrome. Anaesthesia 1976; 31:243-46.

  8. Mc. Crirrick A. Octreotide for carcinoid syndrome. Can J Anaesth 1991; 38:339-40.

  9. Quinlivan J. Kevin. Intraoperative octreotide for refractory carcinoid induced bronchospasm. Anaesth Analg 1994; 78:400-2.

  10. Castheley PA. Ketanserina in the preoperative and intraoperative management of a patient with carcinoid tumour undergoing tricuspid valve replacement. Anesth Analg 1986; 65:809-11.

  11. Miller R. Anaesthesia for the carcinoid syndrome: a report of nine cases. Can Anaesth Soc 1978; 240-4.

  12. Breivik H. Perianaesthetic management of patients with endocrine disease. Acta Anaesth Scand 1996; 40:1004-15.

  13. Veall QRQ. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Brit J Anaesth 1994; 72:335-41.

  14. Pratila M. Propofol infusion in carcinoid syndrome. Can J Anaesth 1991; 38:943-44.

  15. Monteith K. Epidural anaesthesia for transurethral resection of the prostate in a patient with carcinoid syndrome. Can J Anaesth 1990; 37:349-52.

ANESTESIA EN ENFERMEDADES POCO FRECUENTES

Anestesia en el paciente con obesidad mórbida
  1. Leonard L. Anaesthesia secrets. Obesity. Ed. Mc Graw-Hill. Interamericana: 1995; 429-35.

  2. Buckley FP. Anesthesia for the morbidly obese. En: Clinical anesthesia. 2nd. edition Eds. Barash PG, Cullen BF, Stoelting RK, Philadelphia, 1992.

  3. Brown BR, ed. Anesthesia and the obese patient. Contemporary anesthesia practice, FA Davis, Philadelphia, 1982.

  4. Buckley FP. Anesthetizing the morbidly obese patient. ASA Refresher Courses. 1993; 151: 1-6.

  5. Buckley FP. The American Society of Anesthesiologist, Inc., ASA Refresher Courses. 1990; 53-68.

  6. Vaughun RW. Volume and pH gastric juice in obese patients. Anesthesiology 1975; 43: 686-689.

  7. Lee JJ. Airway maintenance in the morbidly obese. Anesthesiology 1980; 7: 33-36.

  8. Berla JB. Obesity and alfentanyl farmacodinamics. Anaesth Analg 1983; 60: 151-52

  9. Bentley JB. Weight, pseudocolinesterase activity and succinilconine requeriments. Anesthesiology 1982; 57: 48-9.

  10. Weinstein JE. Pharmacodinamics of vecuronium in the obese patient. Anesth Analg 1988;67: 1149-53.

  11. Varin F. The influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharm Ther 1990; 48: 18-25.

  12. Taivainen T. Influence of obesity on the spread of spinal analgesia after inyection of 0.5% bupivacaine at the L3 or L5 interspace. Br J Anesth 1990; 65: 542-46.

  13. Catennacci AJ. Ventilation in the obese patient during spinal anesthesia. Anesth Analg 1969; 48: 48-54.

  14. Vaughn RW. Postoperative hipoxemia in obese patients. Ann Surg 1974; 180: 872-77.

  15. Graves DA. Morphine requeriment using patient controlled analgesia. Clin Pharm 1983; 2:49-53.

ANESTESIA Y VIH
  1. Shapiro HM. AIDS and the central nervous system. Anesthesiology 1994; 80: 187-200

  2. Mc Intyre J W. Anaesthesia monitoring. Int J Clin Monit Comput 1993; 10(1): 23-29.

  3. Morgan-M. Checking anaesthetic machine. Anaesthesia 1993; 48-3 pag. 183-186.

  4. Cooper E. Anaesthesia and the child with VIH infection. Can J Anesth 1991; 38 (5): 626-33.

  5. Davies J M. AIDS and hepatitis: A guide for obstetrical anaesthetists. Can J Anesth 1988; 35(3) 273-75.

  6. Lee KG. AIDS and anaesthesia. Anesthesia 1986; 41 (10): 1011-16.

  7. Lipton SA. AIDS related dementia and calcium homeostases. Ann New York Acad Sci 1994;747:205-24.

  8. Lebocitz AH. Pain in hospitalized patient with AIDS. Clin J Pain 1994; 10(2): 156-61.

  9. Glare PA. Palliative care in AIDS. Ann Acad Med Singapore 1994; 23 (2): 235-43.

  10. Butters E. Assesing the symptoms, anxiety and practical needs of aids patients. Qual Life Res 1992; 1(1):47-51

  11. Lekkovitz M. The prevalence and management of pain in patients with AIDS. Clin-J-Pain 1989; 5(3): 245-48.

  12. Jage J. Anesthesia and analgesia in opiate addicts. Anesthesist 1988; 37(8): 470-82.

ANESTESIA EN PACIENTES CON TOXICOMANÍAS
  1. Plessat ST. Drug addiction and anesthesia. Ephitheorese Klin Farmacol 1994; 12: 7-16.

  2. Robinson TE. The neural basic of drug craving. Brain Res Rev 1993; 18:247-91.

  3. Jurado C. Simultaneous quantification of opiates cocaina and cannabinoides in hair. Forensic SCI Int 1995; 70: 165- 74.

  4. Shultz JE. Illicit drugs of abuse. Primary Care 1993 1993; 20: 221- 30

  5. Le Quintrec J. Drug induced myopathies. Baillieres Clinic-Rheumatol 1991; 5: 21- 38.

  6. Laposata EA. A review of pulmonary pathology associated with inhalation of frebease cocaina “crack”. Am J Forensic Med-Pathol 1993; 14: 1-9.

  7. Torres G. A ketamina mixture anesthetic inhibits neuroendocrine and behavioral consecuences of cocaine administration. Brain Res 1994; 656: 33-42.

ANESTESIA PARA EL PACIENTE PEDIÁTRICO CON ALTERACIONES DE LA CONDUCTA
  1. Schachar RJ. The overactive child. Clin Develop Med Philadelphia JB Lippincot Co.1996: 236.

  2. Grossman H.J. Manual on terminology in mental retardation., Washington, D.C. Association on Mental Deficiency, 1977.

  3. Schafer IA Genetics on mental retardation. Thompson, C.H., Rubin, I.I. y Bilenker, R.M. Comprehensive management of cerebral palsy. Nueva York, Grune y Stratton, 1983, p. 61.

  4. Maxwell LG, Deshoande JK, Wetze RC. Evaluacion preoperatoria. Clinicas Pediatricas de Norteamérica 1994; 1: 109-130.

  5. Mash EK. Behavioral interventions and hiperactivity in childrens. Trites R, ed. Baltimore, Univ Park Press, 1978.

  6. Feld LH, Negus JB, White PF. Oral midazolam preanesthetic medication for pediatric outpatient. Anesthesiology 1990; 73:831-4.

  7. Isik D. A comparatison of midazolam and ketamin for paedriatric premedication with respect to psychomotor performance and sedation. Br J Anaest. 1997;Jun: A327,p 100.

  8. Mc Grath PJ, Mc Alpine L. Psychologic perspectives on pediatric pain. J Pediatr 1993; 122: 2-8.

ANESTESIA EN PARÁLISIS CEREBRAL INFANTIL
  1. Nelson N. Tratado de pediatría. 13 edición Interamericana Mc. Graw-Hill 1988, 1411-13

  2. Steward J. Manual de anestesia pediátrica. 1981; 5: 91-96.

  3. Marshall M. Neuroanestesia. México: Salvat Eds,  1981: 29-35.

  4. Bissonnette B. Clínicas de anestesiología de Norte América. 1992; 3: 567-99.

  5. Theroux MC. Response of succinylcoline in cerebral palsy. Anesth Analg 1994; 42: 18-21.

  6. Mooethi K. Resistance to vecuronium in patients with cerebral palsy. Anaesth Analg 1992; 3:469.

  7. Onta K. Epidural opioids for postoperative control in pediatric patients with cerebral palsy. Masui 1993; 43 (95): 664-68.







Contenido